Executive Talent & Leadership Advisory Consultant | Woman in Business & STEM | Active Alumna of Dartmouth College & Tuck School of Business | views are all mine
Luba at Kojin Therapeutics said a beautiful thing about what makes a great leader in biotech:
"One thing that leadership books don't mention, and probably one of the key ingredients for a real leader, especially in biotech and life sciences, which is a difficult industry is very simple: it's to be genuine and love what you do, having a passion for what you do, believing in what you do.
We're in a field of uncertainty and big scientific challenges and hard problems to solve. Those leaders that genuinely love what they do, they show up every day and work side by side with their teams to bring those life-saving medicines to patients. They do well. These are the leaders that inspire their teams to reach that kind of level of success that a lot of the times people think is unimaginable." — @luba_greenwood, CEO at Kojin Therapeutics
Michael J. Fox celebrates the discovery of a biomarker that can detect dysfunction in the protein that goes haywire in Parkinson’s disease. https://t.co/Zp7KapPlg7
@scotthensley Turns out NONE of the dozen or so articles ChatGPT recommended on the topic exist anywhere! Which certainly me question the other seemingly useful info it provided… I guess there’s substitute for good old-fashioned fact-checking yet.
@scotthensley did you ever publish the following? ChatGPT suggested this as a result to my query...and it is nowhere to be found! "Access to Treatment for Depression" by Scott Hensley, NPR (2012)
@emmarcourt did you ever write this or anything related? ChatGPT provided this as a result to my query and I can't find it anywhere... "Depressed patients can't access a breakthrough therapy, and it's a sign our healthcare system is broken" by Emma Court, Business Insider (2018)
@jibbyjaba@Optum I just tried to call the Care Advocate listed on a denial letter from Optum ("this call cannot be completed as dialed") then googled the # and see that @jibbyjaba had the same issue FOUR YEARS ago!? How is this even legal?! @Optum had PLENTY of time to fix.
Biotech women are calling on industry, FDA to help protect women, employees from the impact of Dobbs. “It’s a human rights issue, a health issue that’s central to our industry and our industry’s effort to improve human health." @juliacowens in @BioCentury https://t.co/l04HSMmChZ
In some ways, the anti-science rhetoric is even more intense now than it was in the last election cycle. Read the latest from @owermohle https://t.co/RbJg6WIHKa
Not only is my brother a Sommelier, but I just learned he’s an Executive Bourbon Steward too! Our tendencies to over-achieve may look a little different on paper (and at a bar)…but I love learning about his world (probably more than he loves learning about mine ha) #ProudSister
Exciting job opportunity @DanaFarber for Associate Director scientist to lead our Center for Patient Derived Models and advance the field of functional precision medicine. @CancerModels#precisionmedicine https://t.co/9IwTiEubQw
Congratulations to Dr. Eli Van Allen (@VanAllenLab) & Dr. Nick Wagle (@Nikhilwagle) on receiving the Trailblazer Prize from the Foundation for the National Institutes of Health, recognizing their innovative contributions to advance cancer science & care. https://t.co/PNQe2lLfRB
Understanding cancer risk can be lifesaving. A new online tool developed by @DanaFarber scientists & physicians can accurately & rapidly identify people who should undergo testing for inherited genetic changes that raise the risk of certain cancers. https://t.co/5yNMDQgIhH
Our colleague Dr. Kai Wucherpfennig spoke recently with @thedailybeast about the growing momentum of a cancer vaccine that uses T cells and natural killer cells to target cancer cells and activate the immune system. https://t.co/XEWVVQEohy